YU36200A - Hidrat od 5-(4-2-n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona soli maleinske kiseline - Google Patents
Hidrat od 5-(4-2-n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona soli maleinske kiselineInfo
- Publication number
- YU36200A YU36200A YU36200A YU36200A YU36200A YU 36200 A YU36200 A YU 36200A YU 36200 A YU36200 A YU 36200A YU 36200 A YU36200 A YU 36200A YU 36200 A YU36200 A YU 36200A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- thiazolidine
- hydrate
- ethoxy
- benzyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Hidrat od 5-(4-(2-N-metil-N-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona, so maleinske kiseline naznačen time što: (i) sadrži vodu u opsegu od 0.2 do 1.1% t/t; i (ii) obezbedjuje infracrveni spektar koji sadrži vrhove na 764 i 579 cm-1; i/ili (iii) obezbedjuje uzorak difrakcije praha X-zraka (XRPD) suštinski kako je dato na slici II; postupak za dobijanje takvog jedinjenja, farmaceutskog preparata koji sadrži takvo jedinjenje i primenu takvog jedinjenja ili preparata u medicini.[A hydrate of 5-[4-[2- (N-methyl-N- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, characterised in that it: (i) comprises water in the range of from 0.2 to 1.1 % w/w; and (ii) provides an infrared spectrum containing peaks at 764 and 579 cm- 1; and/or (iii) provides an X-ray powder diffraction (XRPD) pattern substantially as set out in Figure II; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound and the use of such a compound or composition in medicine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726568.0A GB9726568D0 (en) | 1997-12-16 | 1997-12-16 | Novel pharmaceutical |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU36200A true YU36200A (sh) | 2003-12-31 |
| RS50079B RS50079B (sr) | 2009-01-22 |
Family
ID=10823694
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US7045633B2 (sh) |
| EP (1) | EP1045847A1 (sh) |
| JP (1) | JP2002508372A (sh) |
| KR (1) | KR100549143B1 (sh) |
| CN (3) | CN1281454A (sh) |
| AP (1) | AP1441A (sh) |
| AR (2) | AR017213A1 (sh) |
| AU (1) | AU2272399A (sh) |
| BG (1) | BG64905B1 (sh) |
| BR (1) | BR9813604A (sh) |
| CA (1) | CA2314965A1 (sh) |
| CO (1) | CO4990927A1 (sh) |
| CZ (1) | CZ299970B6 (sh) |
| DZ (1) | DZ2680A1 (sh) |
| EA (1) | EA002355B1 (sh) |
| EG (2) | EG21417A (sh) |
| GB (1) | GB9726568D0 (sh) |
| HR (1) | HRP20000405A2 (sh) |
| HU (1) | HUP0100500A3 (sh) |
| ID (1) | ID24744A (sh) |
| IL (1) | IL136381A (sh) |
| IN (1) | IN190821B (sh) |
| MA (1) | MA26582A1 (sh) |
| MY (1) | MY135770A (sh) |
| NO (1) | NO317253B1 (sh) |
| NZ (1) | NZ504704A (sh) |
| OA (1) | OA11634A (sh) |
| PE (1) | PE20000057A1 (sh) |
| PL (1) | PL341147A1 (sh) |
| RS (1) | RS50079B (sh) |
| SK (1) | SK286197B6 (sh) |
| TR (2) | TR200001798T2 (sh) |
| TW (1) | TW467913B (sh) |
| UA (1) | UA63980C2 (sh) |
| UY (2) | UY25305A1 (sh) |
| WO (1) | WO1999031094A1 (sh) |
| ZA (1) | ZA9811505B (sh) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9909041D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Plc | Novel pharmaceutical |
| PE20010045A1 (es) * | 1999-04-23 | 2001-03-10 | Smithkline Beecham Plc | Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| OA11871A (en) * | 1999-04-23 | 2006-03-27 | Smithkline Beecham Plc | Novel pharmaceutical. |
| GB0014005D0 (en) * | 2000-06-08 | 2000-08-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021784D0 (en) * | 2000-09-05 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021978D0 (en) * | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
| WO2003050112A1 (en) * | 2001-12-13 | 2003-06-19 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
| GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| AU2002352391A1 (en) * | 2001-12-13 | 2003-06-23 | Smithkline Beecham Plc | A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus |
| GB0130511D0 (en) * | 2001-12-20 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| AU2002352479A1 (en) * | 2001-12-20 | 2003-07-09 | Smithkline Beecham Plc | 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| US4812570A (en) * | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
| EP0842925A1 (en) | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
| GB9124513D0 (en) | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
| CA2142708A1 (en) | 1992-08-28 | 1994-03-17 | Frank Dininno | Cationic-2-heteroarylphenyl-carbapenem antibacterial agents |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5741803A (en) | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
| TW245716B (sh) * | 1992-12-28 | 1995-04-21 | Takeda Pharm Industry Co | |
| DE4404198A1 (de) | 1994-02-10 | 1995-08-17 | Henkel Kgaa | 2-Fluor-6-nitroaniline |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| GB9726566D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB9726563D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US6664278B2 (en) * | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| CZ432299A3 (cs) * | 1998-06-02 | 2000-08-16 | Smithkline Beecham Plc | Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion |
| OA11871A (en) | 1999-04-23 | 2006-03-27 | Smithkline Beecham Plc | Novel pharmaceutical. |
| PE20010045A1 (es) | 1999-04-23 | 2001-03-10 | Smithkline Beecham Plc | Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona |
| ES2203453T3 (es) | 1999-04-23 | 2004-04-16 | Smithkline Beecham Plc | Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona. |
-
1997
- 1997-12-16 GB GBGB9726568.0A patent/GB9726568D0/en not_active Ceased
-
1998
- 1998-12-14 CA CA002314965A patent/CA2314965A1/en not_active Abandoned
- 1998-12-14 MA MA25392A patent/MA26582A1/fr unknown
- 1998-12-14 ID IDW20001126A patent/ID24744A/id unknown
- 1998-12-14 PL PL98341147A patent/PL341147A1/xx not_active Application Discontinuation
- 1998-12-14 EP EP98966321A patent/EP1045847A1/en not_active Ceased
- 1998-12-14 CN CN98812092A patent/CN1281454A/zh active Pending
- 1998-12-14 OA OA1200000179A patent/OA11634A/en unknown
- 1998-12-14 KR KR1020007006517A patent/KR100549143B1/ko not_active IP Right Cessation
- 1998-12-14 NZ NZ504704A patent/NZ504704A/xx unknown
- 1998-12-14 CZ CZ20002205A patent/CZ299970B6/cs not_active IP Right Cessation
- 1998-12-14 SK SK910-2000A patent/SK286197B6/sk not_active IP Right Cessation
- 1998-12-14 CN CNA2008100930560A patent/CN101412713A/zh active Pending
- 1998-12-14 CN CNA2008100930575A patent/CN101412714A/zh active Pending
- 1998-12-14 AU AU22723/99A patent/AU2272399A/en not_active Abandoned
- 1998-12-14 IL IL13638198A patent/IL136381A/xx unknown
- 1998-12-14 RS YUP-362/00A patent/RS50079B/sr unknown
- 1998-12-14 JP JP2000539018A patent/JP2002508372A/ja not_active Withdrawn
- 1998-12-14 WO PCT/EP1998/008154 patent/WO1999031094A1/en active IP Right Grant
- 1998-12-14 HU HU0100500A patent/HUP0100500A3/hu unknown
- 1998-12-14 AP APAP/P/2000/001830A patent/AP1441A/en active
- 1998-12-14 BR BR9813604-6A patent/BR9813604A/pt not_active Application Discontinuation
- 1998-12-14 UA UA2000063484A patent/UA63980C2/uk unknown
- 1998-12-14 TR TR2000/01798T patent/TR200001798T2/xx unknown
- 1998-12-14 EA EA200000655A patent/EA002355B1/ru not_active IP Right Cessation
- 1998-12-15 ZA ZA9811505A patent/ZA9811505B/xx unknown
- 1998-12-15 EG EG155498A patent/EG21417A/xx active
- 1998-12-15 UY UY25305A patent/UY25305A1/es not_active IP Right Cessation
- 1998-12-15 EG EG155098A patent/EG23694A/xx active
- 1998-12-15 AR ARP980106369A patent/AR017213A1/es not_active Application Discontinuation
- 1998-12-15 UY UY25310A patent/UY25310A1/es not_active IP Right Cessation
- 1998-12-15 DZ DZ980290A patent/DZ2680A1/xx active
- 1998-12-15 AR ARP980106365A patent/AR017430A1/es not_active Application Discontinuation
- 1998-12-15 MY MYPI98005675A patent/MY135770A/en unknown
- 1998-12-16 PE PE1998001232A patent/PE20000057A1/es not_active Application Discontinuation
- 1998-12-16 TW TW087121122A patent/TW467913B/zh not_active IP Right Cessation
- 1998-12-16 IN IN3770DE1998 patent/IN190821B/en unknown
- 1998-12-16 CO CO98074830A patent/CO4990927A1/es unknown
- 1998-12-16 TR TR1998/02626A patent/TR199802626A2/xx unknown
-
2000
- 2000-06-15 NO NO20003068A patent/NO317253B1/no not_active IP Right Cessation
- 2000-06-16 HR HR20000405A patent/HRP20000405A2/hr not_active Application Discontinuation
- 2000-07-11 BG BG104595A patent/BG64905B1/bg unknown
-
2003
- 2003-10-24 US US10/692,544 patent/US7045633B2/en not_active Expired - Fee Related
-
2006
- 2006-03-16 US US11/377,470 patent/US20060189659A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU36400A (sh) | Supstituisani tiazolidinedion derivat, postupak za njegovo dobijanje i njegova farmaceutska primena | |
| YU36200A (sh) | Hidrat od 5-(4-2-n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona soli maleinske kiseline | |
| AP1495A (en) | Thiazolidinedione derivative and its use as antidiabetic. | |
| MY135612A (en) | Novel pharmaceutical | |
| MY131973A (en) | Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2,4-dione,maleic acid salt | |
| AP1607A (en) | Thiazolidinedione derivative and its use as antidiabetic. | |
| NZ515166A (en) | Thiazolidinedione derivative and its use as antidiabetic | |
| AP1680A (en) | Thiazolidinedione derivative and its use as antidiabetic. | |
| ECSP982779A (es) | Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina |